Project ID: 58643

MOFCOM provides Cameroon's Ministry of Public Health with CNY 4 million worth of Anti-Malarial Drugs via 2012 ETCA (Projet de fourniture des médicaments antipaludiques)

Commitment amount

$ 744455.6084431099

Adjusted commitment amount

$ 744455.61

Constant 2021 USD

Summary

Funding agency [Type]

China Ministry of Commerce [Government Agency]

Recipient

Cameroon

Sector

Health (Code: 120)

Flow type

Grant

Infrastructure

No

Category

Intent

Development (The next section lists the possible statuses.)

Commercial

Development

Representational

Mixed

Financial Flow Classification

ODA-like (The next section lists the possible statuses.)

Official Development Assistance

Other Official Flows

Vague (Official Finance)

Flows categorized based on OECD-DAC guidelines

Project lifecycle

Status

Completion (The next section lists the possible statuses.)

Pledge

Commitment

Implementation

Completion

Suspended

Cancelled

Milestones

Commitment

2012-09-25

Actual start

2013-09-25

Actual complete

2013-09-25

Description

On September 25, 2012, China's Ministry of Commerce signed an Economic and Technical Cooperation Agreement (ETCA) with Cameroon's Ministry of Public Health to provide 4 million CNY worth of anti-malarial drugs manufactured in China (Projet de fourniture des médicaments antipaludiques). The anti-malarial drugs were delivered on September 25, 2013. Since 2010, China has put effort into treating malaria in Cameroon as well as other African countries.

Additional details

MOFCOM is the funder but the grant proceed for the drugs were disbursed through a CDB account that was established with a host country bank.

Number of official sources

3

Number of total sources

3

Download the dataset

Details

Cofinanced

No

Direct receiving agencies [Type]

Cameroon Ministry of Public Health [Government Agency]

Implementing agencies [Type]

China Development Bank (CDB) [State-owned Policy Bank]